Lori S Friedman
6PUBLICATIONS
71CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 06, 2025
Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations.Melissa R Junttila, Claire E Repellin, Sumeet Salaniwal
|Oct 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor Immunosuppression.Jared T Moore, Hiroyuki Kawai, Brian R Blank
|Sep 11, 2023
A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer.M Dorso, Payal T Patel, Aleksandr Pankov
|Dec 01, 2022
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα.Emily J Hanan, Marie-Gabrielle Braun, Robert A Heald
|Sep 21, 2021
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy.Kyung W Song, Kyle A Edgar, Emily J Hanan
|Nov 09, 2019
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors.Neil Vasan, Pedram Razavi, Jared L Johnson
Pageof 1
Frequent Collaborators
2 joint publications
Anneleen Daemen
2 joint publications
Brian R Blank
2 joint publications
Melissa R Junttila
2 joint publications
Jae H Chang
2 joint publications
Emily J Hanan
2 joint publications
Sarat Chandarlapaty
1 joint publications
Pedram Razavi
1 joint publications
Alexander I Spira
1 joint publications
Alesia Antoine
1 joint publications
Erik Ladewig
